Skip to content
Partnership for Safe Medicines
  • News
    • Diabetes & Weight-loss Injectables
    • Peptides
    • Fake HIV Medications
      • Diverted HIV Meds on P2P platforms
    • PBMs
    • Botox / Botulism warning
    • Illegal Pill Presses
    • Poisonous cough syrup
    • Counterfeit Pill Crisis
  • Patients
    • About Counterfeits / Save Money Safely
    • Talk to Your Family
    • HIV/HEPC Patients
    • Foreign Online Pharmacies
    • Med spas
    • Mexican Pharmacies
  • Professionals
    • Law Enforcement
    • Pharmacists
    • Doctors
    • Prosecution Document Library
      • Cases we’re following
  • Policy
    • Publications
    • Pharmaceutical Border Security
    • Affordability Boards (PDABs)
    • Alternative funding programs (AFPs)
    • Mass compounding
    • Med spas
    • Illegal Pill Presses
    • Drug Importation
    • PBM under-reimbursement
    • FOIA-ed Materials
    • Events and briefings
  • About Us
    • Join Our Mailing List
    • PSM in the news
    • Press Releases
    • Members
    • PSM Leadership
    • Contact Us
Document Tags: 1:26-cr-00018-RJJ, PDL Brandon Piper, PDL Canada, PDL Canadian pharmacy, PDL GLP-1 agonist, PDL Michigan, PDL misbranded drugs, PDL semaglutide, judgment
Return to library

United States District Court
Western District of Michigan
Southern Division

USA v Brandon Piper

Judgment

July 24, 2026

Read the document.

USA v Brandon Piper, judgment
© 2003-2026 Partnership for Safe Medicines
Click here to contact us.
Facebook Twitter Linkedin Youtube Instagram Email
Scroll To Top